Pharmaceuticals in South Korea
Summary
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South Korean pharmaceuticals market had total revenues of $19,636.6m in 2019, representing a compound annual growth rate (CAGR) of 5.2% between 2015 and 2019.
- South Korea is a growing pharmaceutical market with a strong focus on biosimilars and domestic pharmaceutical manufacturing.
- In recent years, the South Korean government has slowed pharmaceutical market growth through aggressive price cuts and tightening reimbursement criteria for both innovative and generic medicines.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
- Leading company profiles reveal details of key pharmaceuticals market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the South Korea pharmaceuticals market by value in 2019?
- What will be the size of the South Korea pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in South Korea's pharmaceuticals market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. Geography segmentation
1.4. 麻豆原创 share
1.5. 麻豆原创 rivalry
1.6. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. 麻豆原创 share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
8 Company Profiles
8.1. Chong Kun Dang Pharmaceutical Corp
8.2. Daewoong Pharmaceutical Co Ltd
8.3. Hanmi Pharmaceuticals Co Ltd
8.4. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: South Korea pharmaceuticals market value: $ billion, 2015-19
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: South Korea pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: South Korea pharmaceuticals market share: % share, by value, 2019
Table 5: Chong Kun Dang Pharmaceutical Corp: key facts
Table 6: Chong Kun Dang Pharmaceutical Corp: Annual Financial Ratios
Table 7: Chong Kun Dang Pharmaceutical Corp: Key Employees
Table 8: Daewoong Pharmaceutical Co Ltd: key facts
Table 9: Daewoong Pharmaceutical Co Ltd: Annual Financial Ratios
Table 10: Daewoong Pharmaceutical Co Ltd: Key Employees
Table 11: Hanmi Pharmaceuticals Co Ltd: key facts
Table 12: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 13: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios (Continued)
Table 14: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: South Korea size of population (million), 2015-19
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2015-19
Table 21: South Korea gdp (current prices, $ billion), 2015-19
Table 22: South Korea inflation, 2015-19
Table 23: South Korea consumer price index (absolute), 2015-19
Table 24: South Korea exchange rate, 2015-19
List of Figures
List of Figures
Figure 1: South Korea pharmaceuticals market value: $ billion, 2015-19
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: South Korea pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in South Korea, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in South Korea, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in South Korea, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2019
Figure 10: South Korea pharmaceuticals market share: % share, by value, 2019
Chong Kun Dang Pharmaceutical Corp
Daewoong Pharmaceutical Co Ltd
Hanmi Pharmaceuticals Co Ltd
Pfizer Inc.
听
听
*If Applicable.